Products Categories
CAS No.: | 22059-60-5 |
---|---|
Name: | Disopyramid phosphate |
Molecular Structure: | |
Formula: | C21H29N3O.H3O4P |
Molecular Weight: | 437.476 |
Synonyms: | SC 13957;2-Pyridineacetamide,R-[2-[bis(1-methylethyl)- amino]ethyl]-R-phenyl-,phosphate (1:1);Disopyramide phosphate (JAN/USP);Disopyramide phosphate;Rythmodan;Norpace (TN);4-(dipropan-2-ylamino)-2-phenyl-2-pyridin-2-yl-butanamide; phosphoric acid; |
EINECS: | 244-756-1 |
Boiling Point: | 505.2 °C at 760 mmHg |
Flash Point: | 259.4 °C |
Hazard Symbols: | Xn |
Risk Codes: | 22 |
Safety: | 36 |
PSA: | 146.79000 |
LogP: | 3.13360 |
disopyramide phosphate
disopyramide
Conditions | Yield |
---|---|
Stage #1: disopyramide phosphate With sodium hydroxide In n-heptane; water; toluene at 23 - 27℃; for 0.833333h; pH=12.65; Stage #2: at 20 - 46℃; for 4h; Stage #3: at 60℃; under 22.5023 Torr; for 7h; Purification / work up; | 93.7% |
disopyramide phosphate
Conditions | Yield |
---|---|
With Iodine monochloride In acetic acid at 20 - 45℃; for 1.5h; Iodination; | 40% |
potassium tetrakis(4-chlorophenyl)borate
disopyramide phosphate
Conditions | Yield |
---|---|
In ethanol; water ion-pair complex formation; |
What can I do for you?
Get Best Price
MF: C21H32N3O5P
MW: 437.47
EINECS: 244-756-1
Flash Point: 259.4 °C
Enthalpy of Vaporization: 77.49 kJ/mol
Boiling Point: 505.2 °C at 760 mmHg
Vapour Pressure: 2.48E-10 mmHg at 25°C
IUPAC Name: 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide ; phosphoric acid
Synonyms: Disopyramide phosphate ; Disopyramide phosphate salt ; Disopyramid phosphate ; 2-[1-(Ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)]pyridinium phosphate ; Alpha-diisopropylaminoethyl-alpha-phenylpyridine-2-acet-amide phosphate salt ; Rythmodan ; Norpace cr ; Alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-2-pyridineacetamid
Following is the molecular structure of Rythmodan (22059-60-5):
Rythmodan (22059-60-5) belongs to a group ofmedications called antiarrhythmics.This means it acts to correct irregular heartbeats to a normal rhythm and to slow an overactive heart. This allows the heart to work more efficiently.Rythmodan is used to treat and prevent ventricular arrhythmias (irregular heartbeat).Ask your doctor if you have any questions about why Rythmodan has been prescribed for you.
1. | ipr-rat TDLo:1820 mg/kg (male 10W pre):TER | JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 7 (1981),145. | ||
2. | orl-wmn LDLo:60 mg/kg/10D-I:SYS | NYSJAM New York State Journal of Medicine. 83 (1983),1057. | ||
3. | orl-man TDLo:43 mg/kg/5D-I:SYS | NYSJAM New York State Journal of Medicine. 83 (1983),1057. | ||
4. | orl-wmn TDLo:8 mg/kg/1D-I:LIV,BLD | SMJOAV Southern Medical Journal. 75 (1982),496. | ||
5. | orl-man TDLo:1429 µg/kg:SYS | NNGAAS Nippon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine. 72 (1983),1177. | ||
6. | orl-chd LDLo:30 mg/kg | MJAUAJ Medical Journal of Australia. 2 (1978),335. | ||
7. | orl-man TDLo:45 mg/kg/1W-I | SMJOAV Southern Medical Journal. 76 (1983),1453. | ||
8. | orl-wmn TDLo:20 mg/kg/3D-I:CVS,BLD | AHJOA2 American Heart Journal. 105 (1983),870. | ||
9. | orl-rat LD50:880 mg/kg | YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. 9 (Suppl 1)(1981),5. | ||
10. | ipr-rat LD50:255 mg/kg | YACHDS |
Human poison by ingestion. Experimental poison by intravenous and intraperitoneal routes. Moderately toxic experimentally by ingestion and subcutaneous routes. Human systemic effects: arrhythmias, blood clotting factor change, hypoglycemia, liver function tests impaired, pulse rate increase, thrombocytopenia. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and POx.
Safety Information Rythmodan (22059-60-5):
Hazard Codes: Xn
Xn: Harmful
Risk Statements: 22
22: Harmful if swallowed
Safety Statements: 36
36: Wear suitable protective clothing
WGK Germany: 3
RTECS: UR8440000